Brevipsidone (1), a new depsidone was isolated from the methanol extract of the stem bark of Garcinia brevipedicellata together with known damnacanthal (2), pilloin (3), scopoletin (4). The structure of the new compound was determined by analysis of spectroscopic data. Compounds 1-4 were evaluated for their α-glucosidase inhibition effect and showed significant inhibitory activity.
The genus Garcinia (Clusiaceae) is widely distributed in tropical Africa, Asia, New Caledonia and Polynesia [1] . Garcinia species are well known to be rich in a variety of oxygenated and prenylated derivatives [2, 3] . Some of them showed a wide range of biological and pharmacological activities, for example cytotoxic, anti-inflammatory, antimicrobial and antifungal activity [4] . In the course of our ongoing search for biologically active substances from natural sources, a MeOH extract of the stem bark of Garcinia brevipedicellata has been investigated and found to exhibit α-glucosidase inhibition effects. Fractionation of this extract afforded a new depsidone (11H-dibenzo[b,e] [1, 4] dioxepin-11-one derivative), named brevipsidone (1), together with the known compounds damnacanthal (2), pilloin (3), and scopoletin (4) . The isolation and structural determination of the new compound and the α-glucosidase inhibition activity of the isolated compounds are reported herein. To our knowledge, no phytochemical investigation has been carried out on this species. in the digestive process of carbohydrates. Its inhibitors retard the uptake of dietary carbohydrates and thus suppress postprandial hyperglycemia and can be used for the treatment of type II diabetes [5] . Glucosidases are also involved in several important biological processes, such as the synthesis of glycoproteins and the liposomal catabolism of glycoconjugates [6] . Glucosidase inhibitors are potentially useful as antiviral, antimetastatic, and immunomodulatory agents. They are also potentially active against HIV-1 infection [6] . Nojirimycin [7, 8] and acarbose [9] are known to be powerful α-glucosidase inhibitors derived from micro-organisms.
Compound 1 was obtained as a yellow powder, mp 195-197°C. It gave a dark green color with ferric chloride, indicating its phenolic nature. The molecular formula C 15 (Table 1 ). In the aromatic region, an ortho-coupled AB system [δ H 7.37 (1H, d, J = 9.1 Hz) and 7.21 (1H, d, J = 9.1 Hz)] and an ABX system [δ H 7.68 (1H, d, J = 3.1 Hz); 7.36 (1H, d, J = 9.1 Hz) and 7.28 (1H, dd, J = 9.1, 3.1 Hz)] were observed, and suggested tri-and tetra-substituted aromatic rings. Thus, the ten unsaturations of the molecule accounted for two aromatic rings, a carbonyl group and an additional ring. The locations of substituents on the tri-and tetra-substituted aromatic moieties were elucidated by HMBC and NOESY analyses. Correlations observed in the NOESY spectrum between the methoxyl (δ H 3. The second methoxyl and OH group have been located at C-6 (δ C 145.2) and C-7 (δ C 150.3), respectively, as shown in ring B, from the signal observed at δ C 62.6 for this methoxy group, due to a downfield effect of two ortho-substituents [10] [11] [12] and the correlations displayed in the HMBC spectrum between H-8 (δ H 7.21) and C-7 (δ C 150.3), and between H-9 (δ H 7.36) and C-5a (δ C 144.2). This was supported by the observation of NOESY correlation between the methoxy signal δ H 4.02 (6-OMe) and Compounds (1) (2) (3) (4) were evaluated for their α-glucosidase inhibition activity using deoxynojirimycin and acarbose as controls. All tested compounds showed significant α-glucosidase inhibitory activity in a dose-dependent fashion ( Table 2 ). 
Extraction and isolation:
The air-dried and powdered stem bark of G. brevipedicellata (500 g) was macerated in 3L of dichloromethane/methanol (1/1) for two days at room temperature. The extract was evaporated under vacuum to yield 36 g of residue. Of this residue, 30 g was subjected to flash chromatography on silica gel, eluting with n-hexane-CHCl 3 of increasing polarity. Fractions, each of 200 mL, were collected and combined on the basis of their TLC profiles, yielding six main fractions, A (3 g), B (4.5 g), C (2.5 g), D (1.3 g), E (2.0 g) and F (6.0 g). Fractions C, D and E were combined on the basis of TLC and rechromatographed on silica gel with gradient mixtures of n-hexane/CHCl 3 to yield brevipsidone (1) (20 mg) (elution with CHCl 3 / n-hexane 3:7), scopoletin (4) (12 mg) [14] (CHCl 3 / n-hexane 1:1) and damnacanthal (2) (26 mg) [15] (CHCl 3 / n-hexane 6:4). Fraction F was further purified by repeated CC over silica gel, eluting with a gradient mixtures of CHCl 3 /MeOH to afford pilloin (3) (23 mg) [14] . . The enzyme inhibition was measured spectrophotometrically through continuous monitoring of the nitrophenyl produced by the hydrolysis of the substrate p-nitrophenyl α-D-glucopyranoside (PNP-G) (0.7 mM) and 500 milliunits/mL of enzyme used. The enzymatic reaction was performed at 37˚C for 30 minutes. The increment in absorption at 400 nm, due to the hydrolysis of PNP-G by α-glucosidase, was monitored continuously on a microplate spectrophotometer (Spectra Max, Molecular Devices, USA).
Enzyme inhibition assay:
Test compounds were dissolved in a small amount of DMSO. Phosphate saline buffer at pH 6.9 was used, which contains 50 mM sodium phosphate containing 100 mM NaCl. 1-Deoxynojirimycin (0.425 mM) was used as a positive control.
Brevipsidone (1) Yellow powder. MP: 195-197°C. 1 H NMR: Table 1 . 13 C NMR: Table 1 
